Home › Migraine › California › Long Beach
Migraine clinical trials in Long Beach, CA
4 studies for Migraine are looking for participants at sites in and around Long Beach (within about 30 miles). Open a study to see who can join and how to contact the study team.
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
RecruitingPhase 3
- Adult & Child Neurology Medical Associates, Long Beach
- Memorialcare Miller Children's & Women's Hospital Long Beach, Long Beach
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
RecruitingPhase 3
- Adult & Child Neurology Medical Associates, Long Beach
- Miller Children's & Women's Hospital Long Beach, Long Beach
A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
RecruitingPhase 3
- Accellacare - Long Beach /ID# 270398, Long Beach
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
RecruitingPhase 3
- Alliance for Research Alliance for Wellness /ID# 230546, Long Beach
About Migraine
Migraines are pulsing or throbbing headaches in one area of the head. Learn about other symptoms, what triggers migraines, and how to treat them.
More about Migraine on MedlinePlus
Migraine trials in other cities
- Cincinnati, OH11 studies
- Concord, CA8 studies
- Philadelphia, PA8 studies
- Austin, TX8 studies
- Miami, FL8 studies
- Washington, DC7 studies
- Houston, TX7 studies
- Omaha, NE7 studies
- Amherst, NY7 studies
- Tampa, FL6 studies
- Charlotte, NC6 studies
- Orlando, FL6 studies
Other studies in Long Beach
- Non-Small Cell Lung Cancer12 studies
- Type 2 Diabetes11 studies
- Lung Cancer9 studies
- Breast Cancer9 studies
- Alzheimer's Disease8 studies
- Prostate Cancer7 studies
- Cardiovascular Disease6 studies
- Cancer (all types)6 studies
- Overweight5 studies
- Obesity5 studies
- Dementia5 studies
- High Blood Pressure4 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.